Constitutive androstane receptor

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Nuclear receptor subfamily 1, group I, member 3
Protein NR1I3 PDB 1xv9.png
PDB rendering based on 1xv9.
Available structures
PDB Ortholog search: PDBe, RCSB
Symbols NR1I3 ; CAR; CAR1; MB67
External IDs OMIM603881 MGI1346307 HomoloGene3759 IUPHAR: 607 ChEMBL: 5503 GeneCards: NR1I3 Gene
RNA expression pattern
PBB GE NR1I3 207007 at tn.png
More reference expression data
Species Human Mouse
Entrez 9970 12355
Ensembl ENSG00000143257 ENSMUSG00000005677
UniProt Q14994 O35627
RefSeq (mRNA) NM_001077469 NM_001243062
RefSeq (protein) NP_001070937 NP_001229991
Location (UCSC) Chr 1:
161.23 – 161.24 Mb
Chr 1:
171.21 – 171.22 Mb
PubMed search [1] [2]

The constitutive androstane receptor (CAR) also known as nuclear receptor subfamily 1, group I, member 3 is a protein that in humans is encoded by the NR1I3 gene.[1] CAR is a member of the nuclear receptor superfamily and along with pregnane X receptor (PXR) functions as a sensor of endobiotic and xenobiotic substances. In response, expression of proteins responsible for the metabolism and excretion of these substances is upregulated.[2] Hence, CAR and PXR play a major role in the detoxification of foreign substances such as drugs.

Androstenol and several isomers of androstanol, androstanes, are endogenous antagonists of the CAR, and despite acting as antagonists, were the basis for the naming of this receptor.[3] More recently, dehydroepiandrosterone (DHEA), also an androstane, has been found to be an endogenous agonist of the CAR.[4]


CAR is a member of the nuclear receptor superfamily, and is a key regulator of xenobiotic and endobiotic metabolism. Unlike most nuclear receptors, this transcriptional regulator is constitutively active in the absence of ligand and is regulated by both agonists and inverse agonists. Ligand binding results in translocation of CAR from the cytosol into the nucleus, where the protein can bind to specific DNA sites, called response elements. Binding occurs both as a monomer and together with the retinoid X receptor (RXR) resulting in activation or repression of target gene transcription. CAR-regulated genes are involved in drug metabolism and bilirubin clearance. Examples for CAR-regulated genes are members of the CYP2B, CYP2C, and CYP3A subfamilies, sulfotransferases, and glutathione-S-transferases.[5] Ligands binding to CAR include bilirubin, a variety of foreign compounds, steroid hormones, and prescription drugs. [6]

Activation mechanism[edit]

Phosphorylated CAR forms a multiprotein complex with the heat shock protein 90 (hsp90) and the cytoplasmic CAR retention protein (CCRP) which keep CAR in the cytosol thereby inactivating it.[7] CAR can be activated in two ways: by direct binding of a ligand (e.g. TCPOBOP) or indirect regulation by phenobarbital (PB), a common seizure medication, facilitating the dephosphorylation of CAR through protein phosphatase 2 (PP2A) (Fig. 1). Both lead to the release of CAR from the multiprotein complex and its translocation into the nucleus. Here, CAR forms a heterodimer with retinoid X receptor (RXR) and interacts with the phenobarbital-responsive enhancer module (PBREM), a distal enhancer activating transcription of CAR target genes.[8]

The consensus sequence of PBREM, containing direct repeat-4 motifs, was found to be conserved in mouse, rat and human 'Cyp2b' genes.[9][10][11]

Direct activation[edit]

1,4-bis[2-(3,5-dichloropyridyloxy)]benzene (TCPOBOP) is thought to bind directly to mouse CAR, thus inducing its translocation into the nucleus.[12] TCPOBOP does not bind to human CAR and hence has no effect on it. Human CAR can be activated by CITCO (6-(4-chlorophenyl)imidazo(2,1-b)(1,3)thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime).[13]

Indirect activation[edit]

Figure 1 - Activation mechanisms of CAR: Inactivated CAR is retained in the cytosol. Upon binding of TCPOBOP, CAR gets dephosphorylated by PP2A and translocates into the nucleus. Here, it forms a complex with RXR and binds to the PB-responsive enhancer module. Another possibility to activate CAR is the indirect activation through PB. PB binds competitively to EGFR, thus inducing the dephosphorylation of RACK-1. RACK-1 then stimulates PP2A to dephosphorylate CAR, which is then translocated into the nucleus.

Phenobarbital (PB), a widely used anticonvulsant, is used as a model ligand for indirect CAR activation. PB activates CAR, by inducing the dephosphorylation of CAR through PP2A. How PP2A is activated remains unclear, but several different mechanisms have been proposed.[14][15] The recruitment of PP2A has been shown to be mediated by the multiprotein complex. As PB is involved in the activation of AMP-activated protein kinase, it has been suggested that AMPK activates PP2A.[16]

Alternatively, PP2A might be activated through another pathway including the epidermal growth factor receptor (EGFR) and the receptor for activated C kinase 1 (RACK1). In the absence of PB, the epidermal growth factor (EGF) binds to EGFR, thereby activating the steroid receptor coactivator-1 (Src1), which in turn phosphorylates RACK1. Upon PB-exposure, PB binds competitively to EGFR and thus leads to inactivation of Src1. This results in a dephosphorylation of RACK1, which can subsequently stimulate PP2A to activate CAR.[15]


  1. ^ Baes M, Gulick T, Choi HS, Martinoli MG, Simha D, Moore DD (Mar 1994). "A new orphan member of the nuclear hormone receptor superfamily that interacts with a subset of retinoic acid response elements". Molecular and Cellular Biology 14 (3): 1544–52. PMC 358513. PMID 8114692. 
  2. ^ Wada T, Gao J, Xie W (Aug 2009). "PXR and CAR in energy metabolism". Trends in Endocrinology and Metabolism 20 (6): 273–9. doi:10.1016/j.tem.2009.03.003. PMID 19595610. 
  3. ^ Nicholas A. Meanwell (8 December 2014). Tactics in Contemporary Drug Design. Springer. pp. 182–. ISBN 978-3-642-55041-6. 
  4. ^ Kohalmy K, Tamási V, Kóbori L, Sárváry E, Pascussi JM, Porrogi P, et al. (2007). "Dehydroepiandrosterone induces human CYP2B6 through the constitutive androstane receptor". Drug Metab. Dispos. 35 (9): 1495–501. doi:10.1124/dmd.107.016303. PMC 2423426. PMID 17591676. 
  5. ^ Ueda A, Hamadeh HK, Webb HK, Yamamoto Y, Sueyoshi T, Afshari CA, Lehmann JM, Negishi M (Jan 2002). "Diverse roles of the nuclear orphan receptor CAR in regulating hepatic genes in response to phenobarbital". Molecular Pharmacology 61 (1): 1–6. doi:10.1124/mol.61.1.1. PMID 11752199. 
  6. ^ "Entrez Gene: NR1I3 nuclear receptor subfamily 1, group I, member 3". 
  7. ^ Kodama S, Negishi M (2006). "Phenobarbital confers its diverse effects by activating the orphan nuclear receptor car". Drug Metabolism Reviews 38 (1-2): 75–87. doi:10.1080/03602530600569851. PMID 16684649. 
  8. ^ Kawamoto T, Sueyoshi T, Zelko I, Moore R, Washburn K, Negishi M (Sep 1999). "Phenobarbital-responsive nuclear translocation of the receptor CAR in induction of the CYP2B gene". Molecular and Cellular Biology 19 (9): 6318–22. PMC 84602. PMID 10454578. 
  9. ^ Honkakoski P, Moore R, Washburn KA, Negishi M (Apr 1998). "Activation by diverse xenochemicals of the 51-base pair phenobarbital-responsive enhancer module in the CYP2B10 gene". Molecular Pharmacology 53 (4): 597–601. doi:10.1124/mol.53.4.597. PMID 9547348. 
  10. ^ Sueyoshi T, Kawamoto T, Zelko I, Honkakoski P, Negishi M (Mar 1999). "The repressed nuclear receptor CAR responds to phenobarbital in activating the human CYP2B6 gene". The Journal of Biological Chemistry 274 (10): 6043–6. doi:10.1074/jbc.274.10.6043. PMID 10037683. 
  11. ^ Mäkinen J, Frank C, Jyrkkärinne J, Gynther J, Carlberg C, Honkakoski P (Aug 2002). "Modulation of mouse and human phenobarbital-responsive enhancer module by nuclear receptors". Molecular Pharmacology 62 (2): 366–78. doi:10.1074/jbc.274.10.6043. PMID 12130690. 
  12. ^ Tzameli I, Pissios P, Schuetz EG, Moore DD (May 2000). "The xenobiotic compound 1,4-bis[2-(3,5-dichloropyridyloxy)]benzene is an agonist ligand for the nuclear receptor CAR". Molecular and Cellular Biology 20 (9): 2951–8. doi:10.1128/MCB.20.9.2951-2958.2000. PMC 85552. PMID 10757780. 
  13. ^ Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT (May 2003). "Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes". The Journal of Biological Chemistry 278 (19): 17277–83. doi:10.1074/jbc.M300138200. PMID 12611900. 
  14. ^ Yoshinari K, Kobayashi K, Moore R, Kawamoto T, Negishi M (Jul 2003). "Identification of the nuclear receptor CAR:HSP90 complex in mouse liver and recruitment of protein phosphatase 2A in response to phenobarbital". FEBS Letters 548 (1-3): 17–20. doi:10.1016/s0014-5793(03)00720-8. PMID 12885400. 
  15. ^ a b Mutoh S, Sobhany M, Moore R, Perera L, Pedersen L, Sueyoshi T, Negishi M (May 2013). "Phenobarbital indirectly activates the constitutive active androstane receptor (CAR) by inhibition of epidermal growth factor receptor signaling". Science Signaling 6 (274): ra31. doi:10.1126/scisignal.2003705. PMID 23652203. 
  16. ^ Rencurel F, Stenhouse A, Hawley SA, Friedberg T, Hardie DG, Sutherland C, Wolf CR (Feb 2005). "AMP-activated protein kinase mediates phenobarbital induction of CYP2B gene expression in hepatocytes and a newly derived human hepatoma cell line". The Journal of Biological Chemistry 280 (6): 4367–73. doi:10.1074/jbc.M412711200. PMID 15572372. 

Further reading[edit]

  • Masuno M, Shimozawa N, Suzuki Y, Kondo N, Orii T, Tsukamoto T, Osumi T, Fujiki Y, Imaizumi K, Kuroki Y (Mar 1994). "Assignment of the human peroxisome assembly factor-1 gene (PXMP3) responsible for Zellweger syndrome to chromosome 8q21.1 by fluorescence in situ hybridization". Genomics 20 (1): 141–2. doi:10.1006/geno.1994.1144. PMID 8020947. 
  • Choi HS, Seol W, Moore DD (Jan 1996). "A component of the 26S proteasome binds on orphan member of the nuclear hormone receptor superfamily". The Journal of Steroid Biochemistry and Molecular Biology 56 (1-6 Spec No): 23–30. doi:10.1016/0960-0760(95)00220-0. PMID 8603043. 
  • Seol W, Choi HS, Moore DD (May 1996). "An orphan nuclear hormone receptor that lacks a DNA binding domain and heterodimerizes with other receptors". Science 272 (5266): 1336–9. doi:10.1126/science.272.5266.1336. PMID 8650544. 
  • Choi HS, Chung M, Tzameli I, Simha D, Lee YK, Seol W, Moore DD (Sep 1997). "Differential transactivation by two isoforms of the orphan nuclear hormone receptor CAR". The Journal of Biological Chemistry 272 (38): 23565–71. doi:10.1074/jbc.272.38.23565. PMID 9295294. 
  • Seol W, Hanstein B, Brown M, Moore DD (Oct 1998). "Inhibition of estrogen receptor action by the orphan receptor SHP (short heterodimer partner)". Molecular Endocrinology 12 (10): 1551–7. doi:10.1210/me.12.10.1551. PMID 9773978. 
  • Forman BM, Tzameli I, Choi HS, Chen J, Simha D, Seol W, Evans RM, Moore DD (Oct 1998). "Androstane metabolites bind to and deactivate the nuclear receptor CAR-beta". Nature 395 (6702): 612–5. doi:10.1038/26996. PMID 9783588. 
  • Gonzalez MM, Carlberg C (May 2002). "Cross-repression, a functional consequence of the physical interaction of non-liganded nuclear receptors and POU domain transcription factors". The Journal of Biological Chemistry 277 (21): 18501–9. doi:10.1074/jbc.M200205200. PMID 11891224. 
  • Min G, Kim H, Bae Y, Petz L, Kemper JK (Sep 2002). "Inhibitory cross-talk between estrogen receptor (ER) and constitutively activated androstane receptor (CAR). CAR inhibits ER-mediated signaling pathway by squelching p160 coactivators". The Journal of Biological Chemistry 277 (37): 34626–33. doi:10.1074/jbc.M205239200. PMID 12114525. 
  • Goodwin B, Hodgson E, D'Costa DJ, Robertson GR, Liddle C (Aug 2002). "Transcriptional regulation of the human CYP3A4 gene by the constitutive androstane receptor". Molecular Pharmacology 62 (2): 359–65. doi:10.1124/mol.62.2.359. PMID 12130689. 
  • Ferguson SS, LeCluyse EL, Negishi M, Goldstein JA (Sep 2002). "Regulation of human CYP2C9 by the constitutive androstane receptor: discovery of a new distal binding site". Molecular Pharmacology 62 (3): 737–46. doi:10.1124/mol.62.3.737. PMID 12181452. 
  • Zhang J, Huang W, Chua SS, Wei P, Moore DD (Oct 2002). "Modulation of acetaminophen-induced hepatotoxicity by the xenobiotic receptor CAR". Science 298 (5592): 422–4. doi:10.1126/science.1073502. PMID 12376703. 
  • Chang TK, Bandiera SM, Chen J (Jan 2003). "Constitutive androstane receptor and pregnane X receptor gene expression in human liver: interindividual variability and correlation with CYP2B6 mRNA levels". Drug Metabolism and Disposition 31 (1): 7–10. doi:10.1124/dmd.31.1.7. PMID 12485946. 
  • Pascussi JM, Busson-Le Coniat M, Maurel P, Vilarem MJ (Jan 2003). "Transcriptional analysis of the orphan nuclear receptor constitutive androstane receptor (NR1I3) gene promoter: identification of a distal glucocorticoid response element". Molecular Endocrinology 17 (1): 42–55. doi:10.1210/me.2002-0244. PMID 12511605. 
  • Shiraki T, Sakai N, Kanaya E, Jingami H (Mar 2003). "Activation of orphan nuclear constitutive androstane receptor requires subnuclear targeting by peroxisome proliferator-activated receptor gamma coactivator-1 alpha. A possible link between xenobiotic response and nutritional state". The Journal of Biological Chemistry 278 (13): 11344–50. doi:10.1074/jbc.M212859200. PMID 12551939. 
  • Maglich JM, Parks DJ, Moore LB, Collins JL, Goodwin B, Billin AN, Stoltz CA, Kliewer SA, Lambert MH, Willson TM, Moore JT (May 2003). "Identification of a novel human constitutive androstane receptor (CAR) agonist and its use in the identification of CAR target genes". The Journal of Biological Chemistry 278 (19): 17277–83. doi:10.1074/jbc.M300138200. PMID 12611900. 
  • Xie W, Yeuh MF, Radominska-Pandya A, Saini SP, Negishi Y, Bottroff BS, Cabrera GY, Tukey RH, Evans RM (Apr 2003). "Control of steroid, heme, and carcinogen metabolism by nuclear pregnane X receptor and constitutive androstane receptor". Proceedings of the National Academy of Sciences of the United States of America 100 (7): 4150–5. doi:10.1073/pnas.0438010100. PMC 153063. PMID 12644700. 
  • Huang W, Zhang J, Chua SS, Qatanani M, Han Y, Granata R, Moore DD (Apr 2003). "Induction of bilirubin clearance by the constitutive androstane receptor (CAR)". Proceedings of the National Academy of Sciences of the United States of America 100 (7): 4156–61. doi:10.1073/pnas.0630614100. PMC 153064. PMID 12644704. 
  • Auerbach SS, Ramsden R, Stoner MA, Verlinde C, Hassett C, Omiecinski CJ (Jun 2003). "Alternatively spliced isoforms of the human constitutive androstane receptor". Nucleic Acids Research 31 (12): 3194–207. doi:10.1093/nar/gkg419. PMC 162252. PMID 12799447. 

External links[edit]

This article incorporates text from the United States National Library of Medicine, which is in the public domain.